153 related articles for article (PubMed ID: 37800782)
1. NIFK as a potential prognostic biomarker in colorectal cancer correlating with immune infiltrates.
Tan L; He Y; Wu L; Liu S; Peng P; Huang J
Medicine (Baltimore); 2023 Oct; 102(40):e35452. PubMed ID: 37800782
[TBL] [Abstract][Full Text] [Related]
2. The nucleolar protein NIFK accelerates the progression of colorectal cancer via activating MYC pathway.
Xia T; Wang B; Sun L
Biosci Biotechnol Biochem; 2023 Dec; 88(1):26-36. PubMed ID: 37950567
[TBL] [Abstract][Full Text] [Related]
3. NIFK, a Potential Prognostic and Immunological Biomarker in Pan-- Cancer Analysis, Significantly Regulates Proliferation and Metastasis of Colorectal Cancer.
Li Z; Zhou S; Bin T; Shi Y; Zeng L; Li B; Li J; He Y; Zhang C
Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38659266
[TBL] [Abstract][Full Text] [Related]
4. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
5. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
6. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
[TBL] [Abstract][Full Text] [Related]
7. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
8. NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR.
Cai J; Sun H; Chen L; Xie M; Zhuang J; Gao L; Wei XX
Future Oncol; 2021 Jul; 17(19):2489-2498. PubMed ID: 33906370
[TBL] [Abstract][Full Text] [Related]
9. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
10. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
11. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
12. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
13. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
14. The Role of Autophagy in Tumor Immune Infiltration in Colorectal Cancer.
Bian-Fang Y; Dong-Ning W; Dan T; Jian-Yu S; Shi-Yi W; Ben-Jun W; Xin D; Wen-Wen Z; Qing-Feng W; Yan Z
Anal Cell Pathol (Amst); 2022; 2022():2055676. PubMed ID: 35321516
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8
Lin ZB; Long P; Zhao Z; Zhang YR; Chu XD; Zhao XX; Ding H; Huan SW; Pan YL; Pan JH
Int J Biol Sci; 2021; 17(7):1757-1768. PubMed ID: 33994860
[No Abstract] [Full Text] [Related]
16. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]
17. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
18. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
[TBL] [Abstract][Full Text] [Related]
19. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
[Next] [New Search]